MedPath

Safety and Efficacy of Nicardipine for the Control of Blood Pressure After SAH

Completed
Conditions
Subarachnoid Hemorrhage
Intracerebral Hemorrhage
Registration Number
NCT00490464
Lead Sponsor
University of Illinois at Chicago
Brief Summary

The purpose of this research is to explore ways to improve and simplify control of blood pressure in patients with SAH or ICH. This research will be done by comparing tow different medications that are routinely used to help control blood pressure. None of the medications used in this study nor any procedures performed are experimental.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
163
Inclusion Criteria
  • 18-70 years old (inclusive)
  • Admission to NSICU with a diagnosis of SAH or ICH
Exclusion Criteria
  • Patients who are admitted >48 hours after SAH or ICH
  • Readmission or second SAH
  • Readmission or second ICH
  • Large (immediately life threatening) associated intraparenchymal or intraventricular hemorrhage
  • Women who are pregnant

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of Illinois at Chicago, UIC

🇺🇸

Chicago, Illinois, United States

© Copyright 2025. All Rights Reserved by MedPath